appScorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
News & Opinions
Hindustan Bio Sciences reports standalone net profit of Rs 0.08 crore in the June 2024 quarter
4 months ago•Business Standard
Hindustan Bio Sciences reports standalone net profit of Rs 0.05 crore in the December 2022 quarter
1 year ago•Business Standard
Hindustan Bio Sciences reports standalone net loss of Rs 0.07 crore in the September 2022 quarter
2 years ago•Business Standard
Hindustan Bio Sciences reports standalone net loss of Rs 0.39 crore in the March 2022 quarter
2 years ago•Business Standard
Hindustan Bio Sciences reports standalone nil net profit/loss in the December 2021 quarter
2 years ago•Business Standard
Hindustan Bio Sciences reports standalone net loss of Rs 0.06 crore in the September 2021 quarter
3 years ago•Business Standard
Hindustan Bio Sciences reports standalone net loss of Rs 0.08 crore in the June 2021 quarter
3 years ago•Business Standard